5-140795377-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018905.3(PCDHA2):āc.413A>Gā(p.Lys138Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0009 in 1,614,128 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018905.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDHA2 | NM_018905.3 | c.413A>G | p.Lys138Arg | missense_variant | 1/4 | ENST00000526136.2 | NP_061728.1 | |
PCDHA1 | NM_018900.4 | c.2394+6693A>G | intron_variant | ENST00000504120.4 | NP_061723.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDHA2 | ENST00000526136.2 | c.413A>G | p.Lys138Arg | missense_variant | 1/4 | 1 | NM_018905.3 | ENSP00000431748 | P1 | |
PCDHA1 | ENST00000504120.4 | c.2394+6693A>G | intron_variant | 1 | NM_018900.4 | ENSP00000420840 | P1 | |||
ENST00000655235.1 | n.658-6523T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000771 AC: 194AN: 251496Hom.: 1 AF XY: 0.000831 AC XY: 113AN XY: 135922
GnomAD4 exome AF: 0.000919 AC: 1343AN: 1461894Hom.: 1 Cov.: 34 AF XY: 0.000925 AC XY: 673AN XY: 727248
GnomAD4 genome AF: 0.000723 AC: 110AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000658 AC XY: 49AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.413A>G (p.K138R) alteration is located in exon 1 (coding exon 1) of the PCDHA2 gene. This alteration results from a A to G substitution at nucleotide position 413, causing the lysine (K) at amino acid position 138 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at